Fujian Haixi Pharmaceuticals Co., Ltd. (02637)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Chan Hiu Lam | 01-Dec-24 | AuRep | |||
| 01-Dec-24 | 21-Nov-25 | J-CoSec | Resignation. | ||
| 21-Nov-25 | AuRep, Proc Agt | Resignation. | |||
| Chen Guangming | 01-Oct-23 | Dep GM, ED, CSciO | |||
| Chen Shuyi | 01-Jul-22 | 27-May-26 | ED | Retired as Director after the conclusion of the AGM. | |
| Chen Tingze | 04-Aug-26 | ED | |||
| Chen Xia | 01-Apr-16 | ChSup, Sup | |||
| Feng Yan | 09-Oct-25 | MbStrC | |||
| 01-Nov-17 | Dep GM, ED, Co-Fdr, MbStrC | ||||
| Gong Weimin | 01-Oct-22 | ChCC, MbAC, MbStrC | |||
| 01-Oct-22 | 27-May-26 | INED | Retired as Director after the conclusion of the AGM. | ||
| Hu Kai | 01-May-12 | Dep GM | |||
| Kang Xinshan | 09-Oct-25 | ChStrC, MbNC, MbCC | |||
| 01-Mar-12 | Ch, GM, ED, Co-Fdr, AuRep, ChNC, ChStrC, MbCC | ||||
| Lam Sophie Wai Yee | 21-Nov-25 | AuRep | |||
| 21-Nov-25 | 06-Mar-26 | CoSec, J-CoSec, Proc Agt | Resignation. | ||
| 06-Mar-26 | AuRep | Resignation. | |||
| Lau Kwok Yin | 06-Mar-26 | J-CoSec, AuRep, Proc Agt | |||
| Li Junqing | 27-May-26 | ED | |||
| Lin Bin | 27-May-26 | INED, MbAC, MbStrC | |||
| Pu Meiting | 09-Oct-25 | ChAC, MbNC, MbCC | |||
| 01-Dec-24 | INED, ChAC, MbCC, MbNC | ||||
| Wang Shan Shan | 09-Oct-25 | ChNC, ChCC, INED, MbAC | |||
| Wang Shan Shan | 01-Dec-24 | INED | |||
| Wang Shan Shan | 01-Dec-24 | MbAC, MbNC | |||
| Wang Xinkun | 01-Mar-24 | 04-Aug-26 | NED | Retired as a Director upon the conclusion of the 2026 first EGM. | |
| Wu Jiang | 01-Nov-20 | Sup | |||
| Xu Dong | 01-Aug-23 | Non-executive Director | |||
| Xu Dong | 01-Aug-23 | NED | |||
| Xu Lixia | 01-Mar-24 | Sup | |||
| Zhang Junhuan | 01-Oct-21 | BrdSec, CFO, FD, J-CoSec |